Old Web
English
Sign In
Acemap
>
authorDetail
>
mingfen zhu
mingfen zhu
Hoffmann-La Roche
Medicine
Tolerability
Hepatitis B virus
Pharmacokinetics
Placebo
3
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of the safety, tolerability, and pharmacokinetics of RO7049389 in healthy Chinese volunteers.
2021
Clinical and Translational Science
Xiaojie Wu
Sheng Feng
Jing Zhang
Wenhong Zhang
Yuchen Zhang
mingfen zhu
Miriam Triyatni
Na Zhao
Qingyan Bo
Yuyan Jin
Show All
Source
Cite
Save
Citations (0)
Further Evaluation of Coproporphyrins as Clinical Endogenous Markers for OATP1B.
2021
The Journal of Clinical Pharmacology
Sheng Feng
Qingyan Bo
Hugh A. Coleman
Jean Eric Charoin
mingfen zhu
Jim J. Xiao
Yuyan Jin
Show All
Source
Cite
Save
Citations (2)
A five-in-one first-in-human study to assess safety, tolerability, and pharmacokinetics of RO7049389, an inhibitor of hepatitis B virus capsid assembly, after single and multiple ascending doses in healthy participants.
2020
Antimicrobial Agents and Chemotherapy
Sheng Feng
Edward Gane
Christian Schwabe
mingfen zhu
Miriam Triyatni
Julian Zhou
Qingyan Bo
Yuyan Jin
Show All
Source
Cite
Save
Citations (6)
1